CORRECTING and REPLACING California Diagnostics Company Pangea Laboratory Announces Immediate COVID-19 Testing Capacity of 1,000 Samples Per Day

Company Aims to Increase COVID-19 Testing Availability and Reduce the Current Backlog in California

COSTA MESA, Calif.--(BUSINESS WIRE)-- In the fifth paragraph, the first sentence should read: California first responders and healthcare providers seeking Pangea’s testing kits and processing services can contact the company at info@pangealab.com or 1-949-346-9393.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200417005077/en/

Pangea Laboratory COVID-19 sample testing. (Photo: Business Wire)

The corrected release reads:

CALIFORNIA DIAGNOSTICS COMPANY PANGEA LABORATORY ANNOUNCES IMMEDIATE COVID-19 TESTING CAPACITY OF 1,000 SAMPLES PER DAY

Company Aims to Increase COVID-19 Testing Availability and Reduce the Current Backlog in California

Pangea Laboratory, LLC, a clinical testing facility in Orange County, announced its COVID-19 testing capacity of 1,000 samples per day. Pangea’s SARS-CoV-2 testing service is validated for both throat swabs and sputum specimens, and test results are available within 24 hours of sample arrival. The company is investing in increased testing capacity in response to the ongoing coronavirus pandemic. Pangea attributes its high testing volume to a mission-driven team and strategic partnerships with local businesses to secure its supply chain.

California ranks 39th out of 50 states for the number of tests conducted per capita according to an analysis of state testing data by Vox. Additionally, California has an estimated 64 percent of COVID-19 tests that remain unprocessed. Lack of available testing and delayed test results are continued obstacles in overcoming the coronavirus outbreak, as decisions surrounding when to reopen businesses and lift social restrictions rely on accurate case counts and infection monitoring.

“We want COVID-19 testing and results to be accessible to more people. Fast, accurate testing is critical to this fight on multiple levels, as the virus is highly contagious but may also be asymptomatic. Screening remains, and will remain for some time, an important aspect of protecting high risk vulnerable populations, such as immunocompromised and elderly individuals. Our team is committed to doing our part to protect the health of our local communities and our country,” said Dr. Yap Ching Chew, chief operating officer at Pangea Laboratory. “Strategic partnerships with local biotech companies, such as Zymo Research and others, have played a key role in galvanizing our testing capacity, as our reagent supply chain remains secure and allows for future expansion.”

Pangea’s COVID-19 tests have been utilized by first responders, frontline workers, hospitals, and essential local businesses in California. Pangea Laboratory’s CAP-accredited and CLIA-certified lab will also alleviate the current testing backlogs by allowing for the processing of overflow samples from other labs. Pangea is now working on increasing its testing capacity.

California first responders and healthcare providers seeking Pangea’s testing kits and processing services can contact the company at info@pangealab.com or 1-949-346-9393. California residents who believe they have COVID-19 symptoms can contact their local healthcare provider and ask them to submit a request for testing on Pangea Laboratory’s website.

About Pangea® Laboratory

Pangea Laboratory is a California-based diagnostics company focused on the precise, early detection of emerging diseases. Its mission is to have a positive impact on human life by providing medical communities with the data they need to diagnose and treat diseases. Pangea Laboratory, founded in 2014, is headquartered in Costa Mesa, Calif. and is CLIA-certified and CAP-accredited. For more information, visit http://www.pangealab.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200417005077/en/